Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases

Archives of Dermatology

Volumn 134, Issue 8, 1998, Pages 991-994

  Barnhill, Raymond L ^a,e   Piepkorn, Michael W ^c   Cochran, Alistair J ^d   Flynn, Evelyn ^b   Karaoli, Themis ^a   Folkman, Judah ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY KI 67;

APOPTOSIS; ARTICLE; CANCER CYTODIAGNOSIS; CANCER RECURRENCE; CELL PROLIFERATION; HUMAN; HUMAN TISSUE; MELANOMA; METASTASIS; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

EID: 0031929106     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.134.8.991     Document Type: Article

References (12)

1. Crowley N, Seigler H. Relationship between disease-free interval and survival in patients with recurrent melanoma. Arch Surg. 1992;127:1303-1308.
2. Meltzer A. Dormancy and breast cancer. J Surg Oncol.1990;43:181-188.
3. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med. 1995;1:149-153.
4. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1:27-32.
5. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399.
6. Morton DL, Wen DR, Cochran AJ. Management of early stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy or "watch and wait." Surg Oncol Clin North Am. 1992;1:247-259.
7. Barnhill R, Fandrey K, Levy M, Mihm MC Jr, Hyman B. Angiogenesis and tumor progression of the melanoma: quantification of vascularity in melanocytic nevi and cutaneous melanoma. Lab Invest. 1992;67:331-337.
8. Barnhill RL, Levy M. Regressing thin cutaneous malignant melanomas (less than or equal to 1.0 mm) are associated with angiogenesis. Am J Pathol. 1992;143: 99-104.
9. Gerdes J, Becker MHG, Key G, Cattorett G. Immunohistological detection of tumor growth fraction (Ki67 antigen) in formalin-fixed and routinely processes tissues. J Pathol. 1992;168:85.
10. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119: 493-501.
11. Piepkorn M, Barnhill RL. A factual, not arbitrary, basis for choice of resection margins in melanoma. Arch Dermatol. 1996;132:811-814.
12. Piepkorn M, Weinstock MA, Barnhill RL. Theoretical and empirical arguments in relation to elective lymph node dissection for melanoma. Arch Dermatol. 1997; 133:995-1002.